I agree and think we are saying the same or similar things.

We both know NP or the BOD will not sign a merger deal without fair value.....and yes a merger has the potential to unlock some value. IMO there is such a wide disconnect between potential value based on the indications with leronlimab and the current share price that any 'complete' merger of CYDY with a large pharma is not in the cards now. NP just added this 'merger' to his vocabulary a week or so ago....this may be in the cards down the road, but IMO it will begin with a license deal or partnership for one or more indications and eventually may turn into more of a Galapagos type partnership and possibly a merger down the road. This would allow CYDY to unlock some value now (share appreciation) and the BP to gain further insight into these additional indications, making the two sides closer to a merger valuation.

Just my initial thoughts and looking forward to what NP reveals on Thursday. I added shares yesterday in anticipation on finally getting a little of this value unlocked. Best of luck!